Jeanette Leusen, PhDAssociate Professor, Head Immunotherapy Group at UMC Utrecht
Dr. Jeanette Leusen, received her PhD in 1995 at the University of Amsterdam (UvA), The Netherlands, on the topic of the NADPH oxidase of neutrophils studied at Sanquin, Amsterdam. She became a Post-doc at the University Medical Center of Utrecht, first in the Cell Biology department, later Immunology. Her entry into the Fc receptor biology/ therapeutic antibodies field began when she was awarded a prestigious fellowship from the Netherlands Scientific Organization (NWO). In the last 20 years Dr Leusen’s investigated inside-out signalling of several FcR and the consequences for antibody-based therapeutics. Dr Leusen is also scientific founder of TigaTx, exploring IgA as a next generation therapeutic antibody.